Karyopharm Therapeutics Inc (KPTI)
1.105
-0.04
(-3.91%)
USD |
NASDAQ |
Apr 16, 16:00
1.105
0.00 (0.00%)
After-Hours: 19:00
Karyopharm Therapeutics Revenue (TTM): 146.03M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 146.03M |
| September 30, 2023 | 145.87M |
| June 30, 2023 | 146.00M |
| March 31, 2023 | 148.10M |
| December 31, 2022 | 157.07M |
| September 30, 2022 | 249.76M |
| June 30, 2022 | 251.31M |
| March 31, 2022 | 234.23M |
| December 31, 2021 | 209.82M |
| September 30, 2021 | 118.65M |
| June 30, 2021 | 102.29M |
| March 31, 2021 | 113.21M |
| December 31, 2020 | 108.08M |
| September 30, 2020 | 91.08M |
| June 30, 2020 | 82.90M |
| March 31, 2020 | 58.88M |
| December 31, 2019 | 40.89M |
| September 30, 2019 | 23.00M |
| June 30, 2019 | 10.09M |
| March 31, 2019 | 20.49M |
| December 31, 2018 | 30.34M |
| September 30, 2018 | 31.66M |
| Date | Value |
|---|---|
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | 0.166M |
| March 31, 2017 | 0.222M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 0.228M |
| September 30, 2014 | 0.234M |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | 0.433M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
10.09M
Minimum
Jun 2019
251.31M
Maximum
Jun 2022
128.28M
Average
118.65M
Median
Sep 2021
Revenue (TTM) Benchmarks
| Geron Corp | 0.237M |
| Arbutus Biopharma Corp | 18.14M |
| Verastem Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
| Chimerix Inc | 0.324M |